ARTMS Inc. is the global leader in developing technology that transforms the production of the world’s most-used diagnostic imaging isotopes. ARTMS is leveraging the QUANTM Irradiation System (QIS) technology to partner with customers to revolutionize the nuclear medicine industry by enabling global access to cyclotron-produced medical isotopes such as gallium-68, zirconium-89, copper-64 and technetium-99m.